Human Pulmonary Alveolar Proteinosis Associated with a Defect in GM-CSF/IL-3/IL-5 Receptor Common Beta Chain Expression

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1997 Dec 31

PMID 9410898

Citations 55

Authors

U Dirksen

R Nishinakamura

P Groneck

U Hattenhorst

L Nogee

R Murray

S Burdach

Affiliations

Soon will be listed here.

Abstract

Pulmonary alveolar proteinosis (PAP) is a heterogeneous disorder of genetic or acquired etiologies. In some cases congenital PAP is associated with hereditary surfactant protein (SP)-B deficiency. To date, the molecular defect in the majority of patients with PAP has not been identified. In mice, PAP has been generated by targeted deletion of the genes for either the GM-CSF/IL-3/IL-5 receptor common beta chain (beta c) or GM-CSF. Here, we describe an expression defect of beta c in three of seven pediatric patients with PAP and in one patient with severe lung disease suspected to be PAP. The patients failed to express normal levels of beta c as shown by flow cytometry. Strikingly reduced or absent function of beta c was demonstrated by ligand binding studies and progenitor clonogenic assays. Analysis of beta c DNA revealed a point mutation from proline to threonine at codon 602 in one patient. Our findings provide evidence that a defect in the expression of a hematopoietic cytokine receptor is associated with human PAP.

Citing Articles

Interstitial lung disease in the newborn.

Giunta-Stibb H, Hackett B J Perinatol. 2024; 45(1):13-23.

PMID: 38956315 DOI: 10.1038/s41372-024-02036-9.

The ouroboros of autoimmunity.

Casanova J, Peel J, Donadieu J, Neehus A, Puel A, Bastard P Nat Immunol. 2024; 25(5):743-754.

PMID: 38698239 DOI: 10.1038/s41590-024-01815-y.

Towards personalized therapies for genetic disorders of surfactant dysfunction.

Peers de Nieuwburgh M, Wambach J, Griese M, Danhaive O Semin Fetal Neonatal Med. 2023; 28(6):101500.

PMID: 38036307 PMC: 10753445. DOI: 10.1016/j.siny.2023.101500.

Human autoantibodies underlying infectious diseases.

Puel A, Bastard P, Bustamante J, Casanova J J Exp Med. 2022; 219(4).

PMID: 35319722 PMC: 8952682. DOI: 10.1084/jem.20211387.

Chronic myelomonocytic leukemia-associated pulmonary alveolar proteinosis: A case report and review of literature.

Chen C, Huang X, Gao D, Li Y, Qian S World J Clin Cases. 2021; 9(5):1156-1167.

PMID: 33644180 PMC: 7896663. DOI: 10.12998/wjcc.v9.i5.1156.

References

Golde D, Territo M, FINLEY T, Cline M . Defective lung macrophages in pulmonary alveolar proteinosis. Ann Intern Med. 1976; 85(3):304-9. DOI: 10.7326/0003-4819-85-3-304. View

Nishinakamura R, Wiler R, Dirksen U, Morikawa Y, Arai K, Miyajima A . The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation. J Exp Med. 1996; 183(6):2657-62. PMC: 2192618. DOI: 10.1084/jem.183.6.2657. View

Green D, Dighe P, Ali N, Katele G . Pulmonary alveolar proteinosis complicating chronic myelogenous leukemia. Cancer. 1980; 46(8):1763-6. DOI: 10.1002/1097-0142(19801015)46:8<1763::aid-cncr2820460811>3.0.co;2-k. View

Nugent K, Pesanti E . Macrophage function in pulmonary alveolar proteinosis. Am Rev Respir Dis. 1983; 127(6):780-1. DOI: 10.1164/arrd.1983.127.6.780. View

Aymard J, Gyger M, Lavallee R, LEGRESLEY L, Desy M . A case of pulmonary alveolar proteinosis complicating chronic myelogenous leukemia. A peculiar pathologic aspect of busulfan lung?. Cancer. 1984; 53(4):954-6. DOI: 10.1002/1097-0142(19840215)53:4<954::aid-cncr2820530422>3.0.co;2-q. View

Schumacher R, J Marrogi A, Heidelberger K . Pulmonary alveolar proteinosis in a newborn. Pediatr Pulmonol. 1989; 7(3):178-82. DOI: 10.1002/ppul.1950070312. View

Burdach S, Zessack N, Dilloo D, Shatsky M, Thompson D, Levitt L . Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptor. J Clin Invest. 1991; 87(6):2114-21. PMC: 296968. DOI: 10.1172/JCI115242. View

Moulton S, Krous H, Merritt T, ODELL R, Gangitano E, Cornish J . Congenital pulmonary alveolar proteinosis: failure of treatment with extracorporeal life support. J Pediatr. 1992; 120(2 Pt 1):297-302. DOI: 10.1016/s0022-3476(05)80448-2. View

Mahut B, de Blic J, Le Bourgeois M, Beringer A, Chevalier J, Scheinmann P . Partial and massive lung lavages in an infant with severe pulmonary alveolar proteinosis. Pediatr Pulmonol. 1992; 13(1):50-3. DOI: 10.1002/ppul.1950130113. View

10.

Nogee L, de Mello D, Dehner L, Colten H . Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med. 1993; 328(6):406-10. DOI: 10.1056/NEJM199302113280606. View

11.

Spock A . Treatment of congenital alveolar proteinosis. J Pediatr. 1993; 123(3):495-6. DOI: 10.1016/s0022-3476(05)81779-2. View

12.

Nogee L, Garnier G, Dietz H, Singer L, Murphy A, deMello D . A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest. 1994; 93(4):1860-3. PMC: 294267. DOI: 10.1172/JCI117173. View

13.

Dranoff G, Crawford A, Sadelain M, Ream B, Rashid A, Bronson R . Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science. 1994; 264(5159):713-6. DOI: 10.1126/science.8171324. View

14.

Miyamura K, Leigh L, Lu J, Hopkin J, Lopez Bernal A, Reid K . Surfactant protein D binding to alveolar macrophages. Biochem J. 1994; 300 ( Pt 1):237-42. PMC: 1138147. DOI: 10.1042/bj3000237. View

15.

Stanley E, Lieschke G, Grail D, Metcalf D, Hodgson G, Gall J . Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A. 1994; 91(12):5592-6. PMC: 44042. DOI: 10.1073/pnas.91.12.5592. View

16.

deMello D, Nogee L, Heyman S, Krous H, Hussain M, Merritt T . Molecular and phenotypic variability in the congenital alveolar proteinosis syndrome associated with inherited surfactant protein B deficiency. J Pediatr. 1994; 125(1):43-50. DOI: 10.1016/s0022-3476(94)70119-9. View

17.

Wognum A, Westerman Y, Visser T, Wagemaker G . Distribution of receptors for granulocyte-macrophage colony-stimulating factor on immature CD34+ bone marrow cells, differentiating monomyeloid progenitors, and mature blood cell subsets. Blood. 1994; 84(3):764-74. View

18.

Hamvas A, Cole F, deMello D, Moxley M, Whitsett J, Colten H . Surfactant protein B deficiency: antenatal diagnosis and prospective treatment with surfactant replacement. J Pediatr. 1994; 125(3):356-61. DOI: 10.1016/s0022-3476(05)83276-7. View

19.

Nishinakamura R, Nakayama N, Hirabayashi Y, Inoue T, Aud D, McNeil T . Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. Immunity. 1995; 2(3):211-22. DOI: 10.1016/1074-7613(95)90046-2. View

20.

Wright J, Youmans D . Degradation of surfactant lipids and surfactant protein A by alveolar macrophages in vitro. Am J Physiol. 1995; 268(5 Pt 1):L772-80. DOI: 10.1152/ajplung.1995.268.5.L772. View